Itamar Raz Selected Research

Glycosaminoglycans

1/2012	Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.
6/2008	Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
1/2007	The role of sulodexide in the treatment of diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Itamar Raz Research Topics

Disease

104	Type 2 Diabetes Mellitus (MODY) 10/2023 - 04/2003
40	Heart Failure 12/2023 - 04/2003
38	Myocardial Infarction 02/2024 - 04/2003
28	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 02/2003
27	Diabetes Mellitus 11/2021 - 10/2002
17	Hyperglycemia 11/2021 - 02/2003
16	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022 - 10/2002
15	Hypoglycemia (Reactive Hypoglycemia) 10/2021 - 09/2005
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2019 - 04/2003
13	Ischemic Stroke 02/2024 - 06/2015
12	Insulin Resistance 12/2019 - 03/2005
11	Albuminuria 01/2022 - 11/2004
10	Weight Loss (Weight Reduction) 12/2023 - 11/2008
9	Obesity 12/2023 - 01/2005
9	Body Weight (Weight, Body) 12/2023 - 07/2003
9	Kidney Diseases (Kidney Disease) 10/2023 - 01/2018
8	Chronic Renal Insufficiency 01/2023 - 10/2014
7	Infections 01/2023 - 12/2010
7	Stroke (Strokes) 01/2020 - 04/2003
7	Diabetes Complications 01/2011 - 07/2002
6	Glucose Intolerance 08/2009 - 03/2005
5	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 04/2003
5	Atrial Fibrillation 01/2021 - 12/2010
4	Inflammation (Inflammations) 11/2021 - 11/2003
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2019
4	Hypertension (High Blood Pressure) 12/2012 - 01/2003
3	Peripheral Arterial Disease 02/2024 - 01/2019
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
3	Non-alcoholic Fatty Liver Disease 05/2017 - 01/2014
3	Pancreatitis 02/2017 - 10/2013
3	Proteinuria 01/2012 - 01/2007
3	Hypertrophy 03/2011 - 10/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2007 - 03/2005
2	Systolic Heart Failure 10/2023 - 10/2022
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023 - 11/2007
2	Blindness (Hysterical Blindness) 10/2021 - 08/2006
2	Polyneuropathies (Polyneuropathy) 10/2021 - 11/2006
2	Diabetic Neuropathies (Diabetic Neuropathy) 10/2021 - 11/2006
2	COVID-19 10/2021 - 01/2021
2	Weight Gain 12/2019 - 09/2005
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019 - 01/2006
2	Renal Insufficiency (Renal Failure) 01/2018 - 08/2016
2	Fatty Liver 05/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

42	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 07/2003
37	Insulin (Novolin)FDA Link 12/2023 - 01/2003
32	dapagliflozinIBA 10/2023 - 01/2018
25	saxagliptin FDA Link 11/2021 - 10/2010
14	Sodium-Glucose Transport ProteinsIBA 12/2023 - 04/2016
14	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2016
13	CreatinineIBA 10/2023 - 04/2003
10	omega-Chloroacetophenone (Mace)IBA 02/2024 - 01/2018
9	SodiumIBA 01/2023 - 01/2018
9	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2003
9	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 02/2008
8	AlbuminsIBA 10/2023 - 11/2004
8	LipidsIBA 07/2017 - 04/2005
8	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2017 - 11/2011
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2023 - 09/2005
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2016
5	Liraglutide FDA Link 01/2021 - 12/2018
4	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 10/2014
4	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 01/2018
4	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 11/2011
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 03/2012
4	EnzymesIBA 01/2018 - 05/2013
4	Short-Acting InsulinIBA 08/2016 - 05/2009
4	Insulin Glargine (Lantus)FDA Link 04/2013 - 03/2005
4	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 01/2012 - 01/2007
4	Insulin-Like Growth Factor I (IGF-1)IBA 03/2011 - 10/2002
3	Peptides (Polypeptides)IBA 12/2023 - 10/2006
3	Hemoglobins (Hemoglobin)IBA 10/2023 - 01/2016
3	SymportersIBA 01/2023 - 01/2020
3	DiureticsIBA 10/2022 - 07/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2012
3	GlycosphingolipidsIBA 05/2017 - 01/2009
3	Glyburide (Glibenclamide)FDA LinkGeneric 08/2016 - 12/2003
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2016 - 05/2013
3	CopperIBA 03/2014 - 02/2008
3	Glucagon (Glukagon)FDA Link 01/2014 - 05/2011
3	GlycosaminoglycansIBA 01/2012 - 01/2007
3	Angiotensin Receptor AntagonistsIBA 01/2012 - 04/2003
3	insulin aspart protamine drug combination 30:70 insulin aspartIBA 07/2011 - 12/2003
3	Insulin Lispro (Humalog)FDA Link 05/2009 - 03/2005
3	Irbesartan FDA LinkGeneric 07/2005 - 04/2003
2	C-Reactive ProteinIBA 02/2024 - 01/2006
2	Natriuretic PeptidesIBA 12/2023 - 10/2014
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2023 - 10/2020
2	Troponin T (Troponin T1)IBA 11/2021 - 12/2016
2	TicagrelorIBA 01/2021 - 01/2021
2	empagliflozinIBA 04/2016 - 01/2016

Therapy/Procedure

30	Therapeutics 01/2022 - 04/2003
27	Glycemic Control 10/2021 - 07/2002
8	Surgical Amputation (Amputations) 01/2022 - 11/2004
4	Secondary Prevention 01/2021 - 11/2007
3	Injections 01/2019 - 12/2010
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018 - 07/2017
2	Gastrectomy 01/2018 - 07/2017
2	Precision Medicine 01/2018 - 06/2013
2	Bariatric Surgery 07/2017 - 02/2010